The Wrong Message, but the Right Guy

The very misstep that everyone in the electronic age perhaps fears most — sending a message to the wrong recipient — is what brought Victoria Herrmann and Eli Keene together. Both were working at the Carnegie Endowment for International Peace, which is based in Washington. She was a junior fellow in the energy program, focused…

Details

A Zoom Wedding With a Salute to Sweden

Caitlin Ashley DiLena’s exposure to anything Swedish was once limited to trips to Ikea, the Swedish Chef muppet character, and the Swedish princess cake segment on “The Great British Baking Show.” This was before she matched with Nicklas Alexander Ansman Giertz on Tinder in May 2018, and then met him a couple of weeks later…

Details

Coronavirus Spread Speeds Up, Even as Nations Reopen

Here’s what you need to know: ImageA Brazilian man praying at the grave of his grandfather, who died  from Covid-19.Credit…Dado Galdieri for The New York Times The pandemic is growing at a faster pace. The coronavirus pandemic’s pace is quickening worldwide, with nearly 700,000 new known infections reported in the last week after the pathogen…

Details

As Hot Spots Shift, Pandemic Enters a New Phase

Here’s what you need to know: ImageDowntown Los Angeles earlier this month.Credit…Philip Cheung for The New York Times As new hot spots emerge, the pandemic may be entering another phase. The simplest way to track the progress of any outbreak is by seeing how many new cases and deaths are reported in a given area…

Details

Trastuzumab achieves slight reduction in recurrence for women with HER2-positive DCIS

The addition of the monoclonal antibody therapy Trastuzumab to radiotherapy did not reach the protocol objective of a 36% reduction in the ipsilateral breast tumor recurrence rate for women with HER2-positive ductal carcinoma in situ (DCIS) on the NRG Oncology clinical trial NSABP B-43. The trial did find a statistically non-significant, modest (19%) reduction in…

Details

Paid sick leave mandates hold promise in containing COVID-19

ATLANTA—Paid sick leave (PSL) mandates like those found in the federal government’s Families First Coronavirus Response Act may be helping to slow the spread of COVID-19, according to a new study by health economists at Georgia State and Tulane universities. Since 2007, several state and local governments have enacted laws requiring employers to provide their…

Details

Trastuzumab combined with trimodality treatment does not improve outcomes for patients

Results of the NRG Oncology clinical trial RTOG 1010 indicated that the addition of the monoclonal antibody trastuzumab to neoadjuvant trimodality treatment did not improve disease-free survival (DFS) outcomes for patient with HER2 overexpressing local and locally advanced esophageal adenocarcinoma. These results were recently, orally presented during the virtual Annual Meeting of the American Society…

Details

Older men worry less than others about COVID-19

ATLANTA—Older men may be at greater risk of contracting COVID-19 because they worry less about catching or dying from it than women their age or than younger people of both sexes, according to a new study by Sarah Barber, a gerontology and psychology researcher at Georgia State University. This is a concern because older men…

Details

Using brain imaging to demonstrate weaker neural suppression for those with autism

MINNEAPOLIS, MN- May 29, 2020 — According to the National Autism Association, people with autism spectrum disorder (ASD) may experience sensory hypersensitivity. A University of Minnesota Medical School researcher recently published an article in Nature Communications that illustrates why that may be true by showing the differences in visual motion perception in ASD are accompanied…

Details

Combined cediranib and olaparib presents similar activity to standard of care treatment

Results of the NRG Oncology phase III clinical trial NRG-GY004 indicated that the addition of the investigational agent cediranib to olaparib and standard platinum-based chemotherapy did not improve progression-free survival (PFS) outcomes for women with platinum-sensitive ovarian cancer;, however, activity between the treatments were similar in patients. These results were recently presented at the virtual…

Details